Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982357 · ClinicalTrials.gov registry record
Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
A clinical trial of Infant, Premature, Diseases, sponsored by University of California, Irvine.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT01982357: Completed study of Infant, Premature, Diseases, sponsored by University of California, Irvine.
NCT01982357 is a study of Infant, Premature, Diseases that has completed, run by University of California, Irvine. The registered enrollment target is 32 participants, below the 203-participant average among 5 other Infant, Premature, Diseases trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01982357, a study of Infant, Premature, Diseases, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
Conditions Studied
Interventions
- DEVICE Laser Speckle Imaging and Diffuse Optical Spectroscopy
Study Locations (1)
California
- UCIMC - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-07-17 |
| Est. Completion | 2015-06-30 |
What the finished NCT01982357 record still lists
NCT01982357 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 203-participant average among 5 other Infant, Premature, Diseases trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Infant, Premature, Diseases appearing as the primary indexed condition, and to 1 intervention - of which Laser Speckle Imaging and Diffuse Optical Spectroscopy is the first listed.
NCT01982357 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01982357 about?
NCT01982357 is a clinical study titled "Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies". Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
What is the current status of trial NCT01982357?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-07-17. Estimated completion is 2015-06-30.
What conditions does trial NCT01982357 study?
This clinical trial studies the following conditions: Infant, Premature, Diseases.
What interventions are being tested in trial NCT01982357?
The interventions under investigation include: Laser Speckle Imaging and Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT01982357?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01982357 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant, Premature, Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants
RECRUITING · NA
-
PK/PD of Digoxin in Infants With SVHD
RECRUITING · Phase 1
-
Pulmonary Function Using Non-invasive Forced Oscillometry
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI